This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Shutterfly (SFLY) Reports Narrower-Than-Expected Loss in Q1
by Zacks Equity Research
The Lifetouch and Business Solutions segments' robust performances drive Shutterfly's (SFLY) top line in first-quarter 2019.
3 Reasons Why Tucows (TCX) Is a Great Growth Stock
by Zacks Equity Research
Tucows (TCX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
No Trick, 4 Halloween ETF & Stock Treats for Investors (Revised)
by Sanghamitra Saha
Buy these retail stocks and ETFs for the rest of 4Q as Halloween and subsequent holiday events may perk up these investments.
No Tricks, 4 Halloween ETF & Stock Treats for Investors
by Sanghamitra Saha
Buy these retail stocks and ETFs for the rest of 4Q as Halloween and subsequent holiday events may perk up these investments.
YY Inc. (YY) Shows Strength: Stock Adds 9.6% in Session
by Zacks Equity Research
YY Inc. (YY) moved big last session, as its shares jumped almost 10% on the day.
Surging Earnings Estimates Signal Good News for Tucows (TCX)
by Zacks Equity Research
Tucows (TCX) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
Shutterfly (SFLY) Plunges 18% on Q4 Earnings & Sales Miss
by Zacks Equity Research
Shutterfly, Inc. (SFLY) posted weak fourth-quarter 2016 results wherein both the top and bottom lines missed the respective Zacks Consensus Estimates.
Juniper (JNPR) Q4 Earnings Meet Estimates, Revenues Beat
by Zacks Equity Research
Juniper (JNPR) reported fourth-quarter 2016 adjusted earnings of 52 cents per share, which was in line with the Zacks Consensus Estimate.
Buy 5 Leading Stocks with Notable Relative Price Strength
by Nilanjan Choudhury
We ran a screen to select the top 5 stocks with solid relative price strength you want to have.
Zacks.com featured highlights: NVIDIA, Sucampo Pharmaceuticals, Calavo Growers, Tucows and E*TRADE Financial
by Zacks Equity Research
Zacks.com featured highlights: NVIDIA, Sucampo Pharmaceuticals, Calavo Growers, Tucows and E*TRADE Financial
Go Driehaus Way: 5 Momentum Picks
by Zacks Equity Research
Richard Driehaus, a pioneer in momentum investing, developed a strategy that has the potential to yield impressive returns.